Organization Overview
aldesleukin (Proleukin) (4 trials)
allogeneic hematopoietic stem cells (Hemacord) (2 trials)
anastrozole (arimidex) (3 trials)
arsenic trioxide (trisenox) (2 trials)
autologous hematopoietic stem cells (9 trials)
bevacizumab (avastin) (8 trials)
bicalutamide (casodex) (4 trials)
bleomycin (blenoxane) (2 trials)
bupropion (wellbutrin) (1 trial)
capecitabine (xeloda) (2 trials)
carboplatin (paraplatin) (9 trials)
cetuximab (erbitux) (4 trials)
ciprofloxacin (cipro) (1 trial)
cisplatin (platinol) (17 trials)
cyclophosphamide (cytoxan) (22 trials)
dacarbazine (dtic-dome) (3 trials)
daunorubicin (cerubidine) (6 trials)
dexrazoxane (zinecard) (1 trial)
docetaxel (taxotere) (11 trials)
doxorubicin (Doxil) (19 trials)
epirubicin (ellence) (1 trial)
erlotinib (tarceva) (2 trials)
estramustine (emcyt) (4 trials)
etoposide (vepesid) (14 trials)
exemestane (aromasin) (5 trials)
Filgrastim (neupogen) (2 trials)
fludarabine (fludara) (3 trials)
fluorouracil (efudex) (11 trials)
flutamide (eulexin) (3 trials)
gemcitabine (gemzar) (6 trials)
goserelin (zoladex) (4 trials)
ibandronate (boniva) (1 trial)
ketoconazole (nizoral) (2 trials)
levamisole (ergamisol) (2 trials)
loperamide (imodium) (1 trial)
medroxyprogesterone (provera) (1 trial)
mercaptopurine (purinethol) (2 trials)
mitomycin (mutamycin) (1 trial)
mitoxantrone (novantrone) (3 trials)
n-(4-hydroxyphenyl)all-trans retinamide (1 trial)
nicotine (nicorette) (1 trial)
octreotide (sandostatin) (1 trial)
oxaliplatin (eloxatin) (3 trials)
paclitaxel (taxol) (13 trials)
pemetrexed (alimta) (2 trials)
sargramostim (leukine) (13 trials)
selenomethionine se-75 (1 trial)
sorafenib (nexavar) (3 trials)
tamoxifen (nolvadex) (12 trials)
tositumomab (Bexxar) (1 trial)
trastuzumab (herceptin) (5 trials)
triptorelin (Trelstar) (2 trials)
vinblastine (velban) (6 trials)
vincristine (oncovin) (7 trials)
alemtuzumab (campath) (2 trials)
allogeneic lymphocytes (1 trial)
allopurinol (zyloprim) (1 trial)
Adenocarcinoma (Phase 3)
Adenocarcinoma, Bronchiolo-Alveolar (Phase 3)
Adenocarcinoma, Mucinous (Phase 3)
Adenocarcinoma of Lung (Phase 3)
Amyloidosis (Phase 2)
Anus Neoplasms (Phase 3)
Astrocytoma (Phase 1)
Breast Neoplasms (Phase 3)
Breast Neoplasms, Male (Phase 1)
Burkitt Lymphoma (Phase 1)
Carcinoma (Phase 3)
Carcinoma, Acinar Cell (Phase 2)
Carcinoma, Adenoid Cystic (Phase 1)
Carcinoma, Basal Cell (Phase 1)
Carcinoma in Situ (Phase 3)
Carcinoma, Mucoepidermoid (Phase 1)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Carcinoma, Ovarian Epithelial (Phase 3)
Carcinoma, Renal Cell (Phase 3)
Carcinoma, Small Cell (Phase 2)
Carcinoma, Squamous Cell (Phase 1)
Carcinoma, Transitional Cell (Phase 3)
Carcinoma, Verrucous (Phase 1)
Cardiotoxicity (Phase 3)
Colonic Neoplasms (Phase 3)
Colorectal Neoplasms (Phase 3)
Cystadenocarcinoma (Phase 3)
Diarrhea (Phase 3)
Dysgerminoma (Phase 2)
Endometrial Neoplasms (Phase 3)
Ependymoma (Phase 1)
Esophageal Neoplasms (Phase 1)
Esthesioneuroblastoma, Olfactory (Phase 1)
Fatigue (Phase 3)
Germinoma (Phase 2)
Glioblastoma (Phase 1)
Glioma (Phase 1)
Glioma, Subependymal (Phase 1)
Gliosarcoma (Phase 1)
Granuloma (Phase 1)
Head and Neck Neoplasms (Phase 1)
Hodgkin Disease (Phase 3)
Hypereosinophilic Syndrome (Phase 3)
Immunoblastic Lymphadenopathy (Phase 2)
Immunoglobulin Light-chain Amyloidosis (Phase 2)
Infertility (Phase 3)
Inflammatory Breast Neoplasms (Phase 3)
Kidney Neoplasms (Phase 3)
Laryngeal Diseases (Phase 1)
Laryngeal Neoplasms (Phase 1)
Leukemia (Phase 3)
Leukemia, Basophilic, Acute (Phase 3)
Leukemia, Eosinophilic, Acute (Phase 3)
Leukemia, Erythroblastic, Acute (Phase 3)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 3)
Leukemia, Lymphoid (Phase 3)
Leukemia-Lymphoma, Adult T-Cell (Phase 2)
Leukemia, Megakaryoblastic, Acute (Phase 3)
Leukemia, Monocytic, Acute (Phase 3)
Leukemia, Myeloid (Phase 3)
Leukemia, Myeloid, Acute (Phase 3)
Leukemia, Myeloid, Chronic-Phase (Phase 2)
Leukemia, Myelomonocytic, Acute (Phase 3)
Leukemia, Myelomonocytic, Chronic (Phase 3)
Leukemia, Promyelocytic, Acute (Phase 3)
Leukemia, T-Cell (Phase 2)
Liver Neoplasms (Phase 1)
Lung Neoplasms (Phase 3)
Lymphoma (Phase 3)
Lymphoma, B-Cell (Phase 1)
Lymphoma, B-Cell, Marginal Zone (Phase 1)
Lymphoma, Follicular (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 3)
Lymphoma, Large-Cell, Anaplastic (Phase 2)
Lymphoma, Large-Cell, Immunoblastic (Phase 1)
Lymphoma, Mantle-Cell (Phase 1)
Lymphoma, Non-Hodgkin (Phase 3)
Lymphoma, T-Cell (Phase 2)
Lymphoma, T-Cell, Cutaneous (Phase 2)
Lymphomatoid Granulomatosis (Phase 1)
Melanoma (Phase 3)
Mesothelioma (Phase 2)
Multiple Myeloma (Phase 3)
Mycoses (Phase 2)
Mycosis Fungoides (Phase 2)
Myelodysplastic Syndromes (Phase 3)
Nasopharyngeal Carcinoma (Phase 1)
Neoplasms (Phase 3)
Neoplasms, Germ Cell and Embryonal (Phase 3)
Neoplasms, Plasma Cell (Phase 3)
Neoplasms, Unknown Primary (Phase 1)
Neuroectodermal Tumors, Primitive (Phase 1)
Neurotoxicity Syndromes (Phase 3)
Oligodendroglioma (Phase 1)
Oropharyngeal Neoplasms (Phase 1)
Ovarian Neoplasms (Phase 3)
Pancoast Syndrome (Phase 2)
Pancreatic Neoplasms (Phase 3)
Papilloma (Phase 1)
Papilloma, Inverted (Phase 1)
Paranasal Sinus Neoplasms (Phase 1)
Parasomnias (Phase 3)
Philadelphia Chromosome (Phase 2)
Plasmablastic Lymphoma (Phase 1)
Plasmacytoma (Phase 3)
Pleural Effusion (Phase 2)
Pleural Effusion, Malignant (Phase 2)
Precancerous Conditions (Phase 3)
Preleukemia (Phase 3)
Prostatic Intraepithelial Neoplasia (Phase 3)
Prostatic Neoplasms (Phase 3)
Rectal Neoplasms (Phase 3)
Salivary Gland Neoplasms (Phase 1)
Seminoma (Phase 2)
Sezary Syndrome (Phase 2)
Sleep Wake Disorders (Phase 3)
Small Cell Lung Carcinoma (Phase 3)
Syndrome (Phase 3)
Testicular Neoplasms (Phase 3)
Ureteral Neoplasms (Phase 3)
Urethral Neoplasms (Phase 3)
Urinary Bladder Neoplasms (Phase 3)
Uterine Cervical Neoplasms (Phase 1)
Waldenstrom Macroglobulinemia (Phase 1)